Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Industry News

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

September 16, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Daily News

Coronary Calcium Goes Beyond CV Risk to Predict a Spate of Other Diseases

Shelley Wood

March 10, 2016

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

Advertisement

September 2022 News Roundup

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Coronary Calcium Goes Beyond CV Risk to Predict a Spate of Other Diseases

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content